Amphastar - Margin operasi AMPH

Simbol resmi perusahaan Amphastar (AMPH)

Amphastar Pharmaceuticals (AMPH) is developing a hybrid model, supplementing internal research with targeted acquisitions of mature assets. The operating profit margin history demonstrates a steady trajectory, with the indicator fixed at 18.70. High technological barriers ensure a predictable cash flow, while the production of complex injectable drugs for hospitals and pharmacies effectively diversifies market risks.

Amphastar Pharmaceuticals Inc (AMPH): Rentabilitas kegiatan operasi saka 04.07.2022 nganti 19.11.2026

Rincian analitis lan laporan data perusahaan amphastar.com (AMPH)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Amphastar
Produk dadi Amphastar Pharmaceuticals

Full capacity utilization of Amphastar Pharmaceuticals (AMPH) for injectable production directly impacts cost management efficiency. This metric is calculated as the ratio of operating profit to revenue, isolating the effects of debt load and taxes. This allows for an assessment of the actual profitability of production processes and the quality of operational management. The stability of this metric confirms the business's resilience in the current cycle. EBIT margin dynamics help investors timely recognize the risk of reaching a peak in profitability.

Analisis pesaing Amphastar Pharmaceuticals

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.